Navigation Tools

Optimizing Bispecific Antibody Therapy in Multiple Myeloma: A Resource Guide for Nurse and Patient Navigators

The therapeutic landscape of multiple myeloma (MM) has undergone a remarkable evolution over the past 2 decades. The development and application of novel agents and new generations of drugs, such as proteasome inhibitors, immunomodulatory drugs, and monoclonal antibody–based therapies, have resulted in improved prognosis and extended survival of patients with MM. Although these therapeutic advances are opportune and transformative, they add complexity to the MM clinical algorithms.

This resource guide is a review of bispecific antibodies, one of the new therapies currently being studied in clinical trials for patients with relapsed/refractory MM (RRMM), and best practices for oncology nurses and nurse and patient navigators, social workers, care coordinators, and advanced practice providers in supporting patients with RRMM who may be eligible for bispecific antibody–based treatment.

Navigating Multiple Myeloma: The Critical Importance of the First 90 Days

A comprehensive update on multiple myeloma to include diagnostic tests, treatments, and related navigation strategies. Supported by Janssen Pharmaceuticals/Legend Biotech.

Navigating Chronic Lymphocytic Leukemia: The Critical Importance of the First 90 Days

Patients with chronic lymphocytic leukemia (CLL) cannot expect to follow a textbook example of “how CLL is treated,” as each case is different based on patient age, comorbidities, and specifics related to mutations/severity. Veteran navigators offer expert commentary on CLL disease state, treatment considerations, psychosocial impact, and more.

CAR T-Cell Therapy: Implications for Navigation Practice

This 16-page resource is designed for oncology nurse and patient navigators who are caring for patients with multiple myeloma undergoing chimeric antigen receptor (CAR) T-cell therapy.

Hematology Navigation 101

The foundational principles of oncology navigation hold true for all tumor types; however, there are some important distinctions pertaining to the navigation of hematologic malignancies.

Navigation Tracking Sheet for Weekly Rounds

These tracking sheets allow you to record patients’ appointments, prescriptions, lab work, and identify if other important needs have been addressed.

Cancer Care Coordination Questionnaire for Patients

This questionnaire can be used to survey your patients’ experience over the past 3 months of acute oncology treatment. It can help identify the strengths and gaps in patients’ care.

Provider Education on Patient Navigation

The AONN+ Navigation Metrics Subcommittee created a Provider Educational Fact Sheet to help educate physicians and their office staff on the role of the navigator.

AONN+ Navigation Metrics Superheroes

These superheroes represent the 8 domains which encompass the AONN+ standardized navigation metrics and should help navigators to better understand the basis behind each domain and the skills necessary to provide quality patient care and financial stability for their organizations.

GW Cancer Center’s Oncology Patient Navigator Training: The Fundamentals

Through a collaborative process, the George Washington University (GW) Cancer Center developed the first-ever consensus-based competencies for oncology patient navigators without a clinical license. This no-cost, competency-based training uses interactive web-based presentations to discuss evidence-based information and case studies to prepared patient navigators to effectively address barriers to care for cancer patients and survivors.